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Abstract
Clinical trial registries are being increasingly acknowledged worldwide. We searched for possibly trustworthy online
registries that are not already included in the International Clinical Trials Registry Platform to evaluate whether other
useful trial data sources exist and whether they could potentially be consulted, since the strategy search within this
platform has recently been questioned. Fifty-nine registries were initially identified, and 11 of them fit the criteria
applied and were analyzed for quality and usability. Four additional, potentially reliable registries were identified
that researchers could exploit in order to obtain a more global view of the issue being investigated.
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Background
Clinical trial registries are being increasingly acknowl-
edged worldwide. Many registries focusing on specific
populations, conditions, or interventions exist, and were
developed to meet different needs. Currently, policy-
makers and the scientific community are moving, albeit
not without concern, towards the registration of almost
all trial-related information [1].
Despite the fact that multiple mandates have brought
many countries to establish their own regional, national,
or international registries, many trials remain unregis-
tered or registered retrospectively or with poor quality
information [2].
Given that the registration of trials is deemed the first
step in the transparency process, ten years ago the
World Health Organization launched the International
Clinical Trials Registry Platform (ICTRP), which
attempted to harmonize the information originating
from these different registries, generating a more effi-
cient strategy to search for trials. Although this led to a
more realistic picture of the number of trials being car-
ried out worldwide, trial coverage of the ICTRP has
recently been questioned [3, 4]. In this context, charac-
terized by uncertainty in finding all currently registered
clinical trials, we searched for additional online clinical
trial registries in order to assess whether other useful
sources of trial data, beyond the 15 ICTRP platform’s
registries, exist and whether they could potentially be
consulted. In particular, our aim was to provide re-
searchers wishing to find trials on a specific disease or
drug with additional, solid data sources.
Main text
We searched Medline and Embase for papers published
up to July 2015, and Google for direct links to registries
(details are presented in Table 1). We excluded from
analysis registries that were already part of the ICTRP,
were not freely accessible, or were limited to specific
therapeutic areas. We further limited resulting registries
to those (1) whose data was original, i.e., not taken from
another registry, (2) that did not simply provide a title
and refer users to a different registry for additional data,
(3) with English language webpages and trial data, (4)
that were not aimed solely at patient recruitment, (5)
that provided at least minimal search options or separate
data fields describing the intervention or drug, thus per-
mitting at least a visual search through these two fields,
and (6) that provided sufficient trial details.
Two of the authors performed a quality analysis of the
selected registries by checking for the presence of pre-
selected items concerning mainly quality and usability
(see Table 2), and discrepancies were discussed and re-
solved with the third author.
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A total of 59 registries were initially identified: 28
in Europe, 22 in North America, 5 in Asia, and 2 in
both Oceania and South America. When filtered
based on the above-mentioned criteria, only 11 regis-
tries resulted (Table 2), and the analysis of the pre-
selected items had a good inter-rater agreement (90%
agreement, kappa = 0.79).
Concerning quality and usability, the option to limit a
search by trial status (e.g., ongoing versus recruiting)
was only provided by 7/11 registries, while multilingual-
ism of the trial data was a characteristic in four of the
seven non-solely-English speaking countries. None of
the registries track study changes or the date of last up-
date of each trial record, show additional study identi-
fiers, or provide links to publications. In general, the
registries fulfilled few of the quality criteria.
Overall, 6/11 registries were public service registries
funded and managed by public entities. Limitations on
the trials accepted for registration were mostly related to
the country (or research institute) of origin of the trials,
because most of the registries were local. None explicitly
stated that observational studies could be registered.
The search options provided varied, and only 6 registries
permitted the user to see, or calculate, the total number
of registered trials (Table 2). This number was checked
again in September 2016, before publication, and up-
dated values are listed in a footnote to Table 2. Regret-
tably, none of the registries had a section for trial
results.
Four of the clinical trial registries (HKClinicalTrials,
NMRR, REec, Mario Negri) provide data that fulfill the
list of pre-selected items on quality and usability (e.g.,
randomization, blinding, inclusion/exclusion criteria),
resulting as more aligned, in terms of transparency, with
the ICTRP’s 15 registries.
Conclusions
Transparent reporting of clinical trials is vital for de-
cision making. Registries, initially designed to store
only basic information, will soon likely be modified
and expanded to hold additional data, such as clinical
study reports and individual patient data, and will
evolve to become a point of reference for evidence-
based medicine [5, 6].
The greatest achievement of the ICTRP is that any in-
vestigator, from any region of the world, can easily and
freely consult the “portfolio” of trials registered in any of
the approved registries. The real number of trials con-
ducted all over the world, however, remains unknown,
and the fact that searching the ICTRP as a whole yielded
fewer results than searching the individual trial registries
led us to this search [3, 4].
Identifying registries that collect original data and that
are not already included in the ICTRP platform was dif-
ficult to perform, and the most efficient search strategy
was the Google search. We found that, except for coun-
tries such as Iran, South Africa, Brazil, and Cuba, regis-
tries have been set up almost exclusively by higher
income countries. Some areas of the globe, such as the
Middle East, Africa, and Latin America, representing
many lower income countries, still do not have locally or
nationally representative registries. Researchers have
found that the establishment, usually on a voluntary
basis, of national and local-language registries has a sig-
nificant impact on the proportion of trials registered in a
country [7]. Considering that a large proportion of clin-
ical trials may involve low- to lower-middle income
countries [8, 9], and that this percentage is expected to
grow following the increasing worldwide initiatives , this
may represent an essential data “incubator” for the glo-
bal knowledge base. Mandates are still lacking in most
areas of the world [7], and the lack of systematic ap-
proaches results in a dispersal of information and re-
sources. Several countries, however, do not have enough
resources or have limited Internet access [10], and their
only way to make their research public is through exist-
ing international registries.
Registries identified through our study differ in size
and search options provided, permitting different search-
ing sensitivities and leading to differences in complete-
ness of results. Our assessment shows that four
additional, potentially solid sources of trial data may
exist that researchers could exploit in order to obtain a
more global view of the issue being investigated. Two of
the registries analyzed, however, have been modified in
the last few months. The Spanish registry, REec, has
been improved, and the NIHR’s Portfolio database
(NIHR-CRN) is now provided through the UK Clinical
Trials Gateway website (https://www.ukctg.nihr.ac.uk/)
and no longer fits our selection criteria. Possible changes
to the sources of trial data should be considered specific-
ally in a future, ad hoc evaluation of the reliability and
accuracy of these sources, as this topic was beyond the
scope of this commentary.
The information held in the registries has many audi-
ences, from patients to health care providers, researchers,
Table 1 Medline, Embase, and Google search strategies
The Medline search strategy involved combinations of free text terms
with search terms chosen from the database’s Medical Subject Headings
(MeSH) and included: “internet”[Mesh] AND ((“registries”[Mesh] OR
registries[Title/Abstract]) AND (trial[Title/Abstract] OR trials[Title/
Abstract]). Similarly, the Embase search was based on the terms chosen
from the Emtree thesaurus: (‘register’/exp AND ‘internet’/exp AND
‘clinical study’/exp). The Google search, aimed at finding links
concerning registries, involved the same keywords as the database
searches, in addition to several synonyms. The bibliographies of selected
articles were examined to identify additional relevant studies, and
several websites were searched for links to additional registries.
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pharmaceutical companies, and regulators. Their role in
systematic reviews is also being increasingly recognized
[11]. The setting up of local/national registries is funda-
mental for making data more accessible locally, e.g., in a
country’s own language, but cannot be fully exploited, for
example by the ICTRP, due to lack of homogeneity in
quantity and quality of data provided. The proliferation
of registries inevitably imposes a bigger regulatory bur-
den due to the need for standardization of informa-
tion, greater usability and transparency, and routine
checks for completeness and internal consistency.
The ICTRP represents a potent effort towards data ac-
cessibility, albeit with room for improvement, both in
searching capacity and in trial coverage [3, 4]. The four
registries we identified, whose greater usability and data
quality are more aligned with those of the ICTRP’s regis-
tries, could potentially be considered for inclusion in its
platform. Unless worldwide legislation is put into place,
however, establishing homogeneous criteria in trial
documentation, and allowing registries to become com-
mon information sources, even this enormous effort will
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